Condition

Relapsed/Refractory Small Cell Lung Cancer clinical trials and research

• 2Clinical trials
• 6Countries

All recruiting trials (2)

• BMS-986525 alone and with nivolumab for relapsed or refractory small cell lung cancer

  This trial will test whether BMS-986525, alone or together with nivolumab, is safe and tolerable for people whose small cell lung cancer has returned or not responded to prior platinum chemotherapy.

  Recruiting at 10 sites Phase 1/2 Bristol-Myers Squibb · Detroit, Michigan and 12 other locations · NCT07325136

• GC511B CAR-T therapy for DLL3-positive relapsed or refractory small cell lung cancer

  This trial will test GC511B CAR-T cells in adults whose small cell lung cancer has come back or not responded and shows DLL3, to see if the treatment is safe and can shrink tumors.

  Recruiting at 2 sites Phase 1 Cancer Institute and Hospital, Chinese Academy of Medical Sciences · Beijing, Beijing Municipality and 1 other locations · NCT07249879

Quick answers

How many Relapsed/Refractory Small Cell Lung Cancer clinical trials are recruiting right now?

2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 6 countries. The most sites are in China (2 trials), Italy (1 trial), Japan (1 trial), Romania (1 trial), Spain (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 1: 1, Phase 1/2: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →